H.C. Wainwright Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NASDAQ: ZVRA) | Delayed: 10.28 -0.08 (0.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.36 | 52 Week High | $ | |||
| Open | $10.35 | 52 Week Low | $ | |||
| Day High | $10.49 | P/E | N/A | |||
| Day Low | $10.15 | EPS | $ | |||
| Volume | 642,042 | |||||
